Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.

Haque I, Ghosh A, Acup S, Banerjee S, Dhar K, Ray A, Sarkar S, Kambhampati S, Banerjee SK.

BMC Cancer. 2018 Jan 25;18(1):99. doi: 10.1186/s12885-018-3993-6.

2.

Colistin-Resistant Klebsiella Infections Among Pediatric Oncology and Hematopoietic Stem Cell Transplantation Patients in Eastern India.

Chandy M, Das A, Bhattacharyya A, Banerjee S, Dhar K, Goel G, Bhattacharya S.

Infect Control Hosp Epidemiol. 2018 Jan;39(1):118-121. doi: 10.1017/ice.2017.247. Epub 2017 Nov 27. No abstract available.

PMID:
29173228
3.

Mortality associated with candidemia in non-neutropenic cancer patients is not less compared to a neutropenic cohort of cancer patients.

Goel G, Chandy M, Bhattacharyya A, Banerjee S, Chatterjee S, Mullick S, Sinha S, Sengupta K, Dhar K, Bhattacharya S, Rudramurthy S, Chakrabarti A.

Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2533-2535. doi: 10.1007/s10096-017-3078-5. Epub 2017 Aug 11. No abstract available.

PMID:
28801726
4.

Exploring the prescribing behaviours and the mind of antibiotic prescribers is critical for a successful antibiotic stewardship programme: Results of a survey from Eastern India.

Ravi N, Laha A, Hmar L, Chatterjee S, Goswami J, Goel G, Dhar K, Ghosh T, Chatterjee S, Datta SS, Bhattacharya S.

Indian J Med Microbiol. 2017 Apr-Jun;35(2):299-301. doi: 10.4103/ijmm.IJMM_17_133.

5.

Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.

Das A, Dhar K, Maity G, Sarkar S, Ghosh A, Haque I, Dhar G, Banerjee S, Banerjee SK.

Sci Rep. 2017 Apr 27;7(1):1220. doi: 10.1038/s41598-017-00916-z.

6.

Simple, efficient and economical methods for isolation and estimation of novel isoflavone using RP-HPLC.

Alam A, Naik KK, Upadhaya NK, Kumar S, Dhar KL.

MethodsX. 2017 Feb 23;4:128-133. doi: 10.1016/j.mex.2017.02.001. eCollection 2017.

7.

Isolation of isoflavones from Iris kashmiriana Baker as potential anti proliferative agents targeting NF-kappaB.

Alam A, Jaiswal V, Akhtar S, Jayashree BS, Dhar KL.

Phytochemistry. 2017 Apr;136:70-80. doi: 10.1016/j.phytochem.2017.01.002. Epub 2017 Jan 18.

PMID:
28108024
8.

Targeted myocardial gene expression in failing hearts by RNA sequencing.

Dhar K, Moulton AM, Rome E, Qiu F, Kittrell J, Raichlin E, Zolty R, Um JY, Moulton MJ, Basma H, Anderson DR, Eudy JD, Lowes BD.

J Transl Med. 2016 Nov 25;14(1):327.

9.

Engineering of Corynebacterium glutamicum for xylitol production from lignocellulosic pentose sugars.

Dhar KS, Wendisch VF, Nampoothiri KM.

J Biotechnol. 2016 Jul 20;230:63-71. doi: 10.1016/j.jbiotec.2016.05.011. Epub 2016 May 13.

PMID:
27184428
10.

Failed caudal block in a child with pelvic neuroblastoma.

Nisa N, Sunkesula G, Dhar KJ.

Paediatr Anaesth. 2016 May;26(5):568-9. doi: 10.1111/pan.12891. No abstract available.

PMID:
27059421
11.

A Conserved Helicobacter pylori Gene, HP0102, Is Induced Upon Contact With Gastric Cells and Has Multiple Roles in Pathogenicity.

Bhattacharya S, Mukherjee O, Mukhopadhyay AK, Chowdhury R, Pal AK, Dhar KK.

J Infect Dis. 2016 Jul 15;214(2):196-204. doi: 10.1093/infdis/jiw139. Epub 2016 Apr 7. Erratum in: J Infect Dis. 2016 Oct 1;214(7):1127.

PMID:
27056952
12.

Lipase catalysis in organic solvents: advantages and applications.

Kumar A, Dhar K, Kanwar SS, Arora PK.

Biol Proced Online. 2016 Jan 13;18:2. doi: 10.1186/s12575-016-0033-2. eCollection 2016. Review.

13.

Down-regulation of hsa-miR-1264 contributes to DNMT1-mediated silencing of SOCS3.

Boosani CS, Dhar K, Agrawal DK.

Mol Biol Rep. 2015 Sep;42(9):1365-76. doi: 10.1007/s11033-015-3882-x.

14.

Curcumin-Zn(II) complex for enhanced solubility and stability: an approach for improved delivery and pharmacodynamic effects.

Sareen R, Jain N, Dhar KL.

Pharm Dev Technol. 2016 Aug;21(5):630-5. doi: 10.3109/10837450.2015.1041042. Epub 2015 Apr 29.

PMID:
25923136
15.

Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer.

Povolotskaya N, Das N, Dhar K, Brinkmann D, Gardner F, Woolas R.

Surg Res Pract. 2014;2014:497478. doi: 10.1155/2014/497478. Epub 2014 Feb 27.

16.

Investigation of the initial steps of the electrochemical reduction of CO2 on Pt electrodes.

Dhar K, Cavallotti C.

J Phys Chem A. 2014 Sep 25;118(38):8676-88. doi: 10.1021/jp505347k. Epub 2014 Sep 12.

PMID:
25188006
17.

Curcumin loaded microsponges for colon targeting in inflammatory bowel disease: fabrication, optimization, and in vitro and pharmacodynamic evaluation.

Sareen R, Nath K, Jain N, Dhar KL.

Biomed Res Int. 2014;2014:340701. doi: 10.1155/2014/340701. Epub 2014 Jul 1.

18.

Anticancer hybrids--a patent survey.

Nepali K, Sharma S, Kumar D, Budhiraja A, Dhar KL.

Recent Pat Anticancer Drug Discov. 2014;9(3):303-39. Review.

PMID:
24846460
19.

Pancreatic tumor cell secreted CCN1/Cyr61 promotes endothelial cell migration and aberrant neovascularization.

Maity G, Mehta S, Haque I, Dhar K, Sarkar S, Banerjee SK, Banerjee S.

Sci Rep. 2014 May 16;4:4995. doi: 10.1038/srep04995.

20.

pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.

Sareen R, Jain N, Rajkumari A, Dhar KL.

Drug Deliv. 2016;23(1):55-62. doi: 10.3109/10717544.2014.903534. Epub 2014 Apr 24.

PMID:
24758141
21.

Mucoadhesive microparticulate drug delivery system of curcumin against Helicobacter pylori infection: Design, development and optimization.

Ali MS, Pandit V, Jain M, Dhar KL.

J Adv Pharm Technol Res. 2014 Jan;5(1):48-56. doi: 10.4103/2231-4040.126996.

22.

Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.

Nepali K, Sharma S, Sharma M, Bedi PM, Dhar KL.

Eur J Med Chem. 2014 Apr 22;77:422-87. doi: 10.1016/j.ejmech.2014.03.018. Epub 2014 Mar 12. Review.

PMID:
24685980
23.

Development and optimization of osmotically controlled asymmetric membrane capsules for delivery of solid dispersion of lycopene.

Jain N, Sareen R, Mahindroo N, Dhar KL.

ScientificWorldJournal. 2014 Jan 29;2014:438528. doi: 10.1155/2014/438528. eCollection 2014.

24.

Immunomodulatory potential of a bioactive fraction from the leaves of Phyllostachys bambusoides (bamboo) in BALB/c mice.

Kumar S, Sharma G, Sidiq T, Khajuria A, Jain M, Bhagwat D, Dhar KL.

EXCLI J. 2014 Feb 17;13:137-50. eCollection 2014.

25.

Simplified staging laparotomy in FIGO stage 1 epithelial ovarian cancer: follow-up and outcomes in south Wales, U.K.

Beena A, Howells R, Lutchman-Singh K, Dhar K, Lim K, Jones R, Hudson E, Bertelli G.

J Obstet Gynaecol. 2013 Nov;33(8):888-91. doi: 10.3109/01443615.2013.834305.

PMID:
24219736
26.

Psoralea corylifolia L. (Buguchi) - folklore to modern evidence: review.

Chopra B, Dhingra AK, Dhar KL.

Fitoterapia. 2013 Oct;90:44-56. doi: 10.1016/j.fitote.2013.06.016. Epub 2013 Jul 4. Review.

PMID:
23831482
27.

Tubulin inhibitors: a patent survey.

Nepali K, Ojha R, Sharma S, Bedi PM, Dhar KL.

Recent Pat Anticancer Drug Discov. 2014 May;9(2):176-220. Review.

PMID:
23746164
28.

Studies on structural and physical characteristics of a novel exopolysaccharide from Pseudozyma sp. NII 08165.

Sajna KV, Sukumaran RK, Gottumukkala LD, Jayamurthy H, Dhar KS, Pandey A.

Int J Biol Macromol. 2013 Aug;59:84-9. doi: 10.1016/j.ijbiomac.2013.04.025. Epub 2013 Apr 15.

PMID:
23597707
29.

Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors.

Kumar S, Mehndiratta S, Nepali K, Gupta MK, Koul S, Sharma PR, Saxena AK, Dhar KL.

Org Med Chem Lett. 2013 Mar 3;3(1):3. doi: 10.1186/2191-2858-3-3.

30.

Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease.

Sareen R, Jain N, Dhar KL.

Curr Drug Deliv. 2013 Oct;10(5):564-71.

PMID:
23360241
31.

SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells.

Dhar K, Rakesh K, Pankajakshan D, Agrawal DK.

Am J Physiol Heart Circ Physiol. 2013 Mar 15;304(6):H776-85. doi: 10.1152/ajpheart.00570.2012. Epub 2013 Jan 18.

32.

Novel method to differentiate 3T3 L1 cells in vitro to produce highly sensitive adipocytes for a GLUT4 mediated glucose uptake using fluorescent glucose analog.

Vishwanath D, Srinivasan H, Patil MS, Seetarama S, Agrawal SK, Dixit MN, Dhar K.

J Cell Commun Signal. 2013 Jun;7(2):129-40. doi: 10.1007/s12079-012-0188-9. Epub 2013 Jan 6.

33.

Aminopeptidase from Streptomyces gedanensis as a useful tool for protein hydrolysate preparations with improved functional properties.

Rahulan R, Dhar KS, Nampoothiri KM, Pandey A.

J Food Sci. 2012 Jul;77(7):C791-7. doi: 10.1111/j.1750-3841.2012.02773.x.

PMID:
22757700
34.

Real-time monitoring of RAG-catalyzed DNA cleavage unveils dynamic changes in coding end association with the coding end complex.

Wang G, Dhar K, Swanson PC, Levitus M, Chang Y.

Nucleic Acids Res. 2012 Jul;40(13):6082-96. doi: 10.1093/nar/gks255. Epub 2012 Mar 20.

35.

Corynebacterium glutamicum as a potent biocatalyst for the bioconversion of pentose sugars to value-added products.

Gopinath V, Murali A, Dhar KS, Nampoothiri KM.

Appl Microbiol Biotechnol. 2012 Jan;93(1):95-106. doi: 10.1007/s00253-011-3686-4. Epub 2011 Nov 18. Review. Erratum in: Appl Microbiol Biotechnol. 2012 Jan;93(1):451-3.

PMID:
22094976
36.

Synthesis and Biological Evaluation of Chalcones having Heterosubstituent(s).

Sweety, Kumar S, Nepali K, Sapra S, Suri OP, Dhar KL, Sarma GS, Saxena AK.

Indian J Pharm Sci. 2010 Nov;72(6):801-6. doi: 10.4103/0250-474X.84602.

37.

N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors.

Nepali K, Agarwal A, Sapra S, Mittal V, Kumar R, Banerjee UC, Gupta MK, Satti NK, Suri OP, Dhar KL.

Bioorg Med Chem. 2011 Sep 15;19(18):5569-76. doi: 10.1016/j.bmc.2011.07.039. Epub 2011 Jul 26.

PMID:
21862335
38.

Production of leucine amino peptidase in lab scale bioreactors using Streptomyces gedanensis.

Rahulan R, Dhar KS, Madhavan Nampoothiri K, Pandey A.

Bioresour Technol. 2011 Sep;102(17):8171-8. doi: 10.1016/j.biortech.2011.06.037. Epub 2011 Jun 14.

PMID:
21733679
39.

Suppressor of cytokine signaling-3 and intimal hyperplasia in porcine coronary arteries following coronary intervention.

Gupta GK, Dhar K, Del Core MG, Hunter WJ 3rd, Hatzoudis GI, Agrawal DK.

Exp Mol Pathol. 2011 Aug;91(1):346-52. doi: 10.1016/j.yexmp.2011.04.004. Epub 2011 Apr 22.

40.

A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors.

Nepali K, Singh G, Turan A, Agarwal A, Sapra S, Kumar R, Banerjee UC, Verma PK, Satti NK, Gupta MK, Suri OP, Dhar KL.

Bioorg Med Chem. 2011 Mar 15;19(6):1950-8. doi: 10.1016/j.bmc.2011.01.058. Epub 2011 Feb 23.

PMID:
21353569
41.

Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis.

Haque I, Mehta S, Majumder M, Dhar K, De A, McGregor D, Van Veldhuizen PJ, Banerjee SK, Banerjee S.

Mol Cancer. 2011 Jan 13;10:8. doi: 10.1186/1476-4598-10-8.

42.

A unique immuno-stimulant steroidal sapogenin acid from the roots of Asparagus racemosus.

Sharma P, Chauhan PS, Dutt P, Amina M, Suri KA, Gupta BD, Suri OP, Dhar KL, Sharma D, Gupta V, Satti NK.

Steroids. 2011 Mar;76(4):358-64. doi: 10.1016/j.steroids.2010.12.006. Epub 2010 Dec 21.

PMID:
21172369
43.

Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1.

Dhar K, Dhar G, Majumder M, Haque I, Mehta S, Van Veldhuizen PJ, Banerjee SK, Banerjee S.

Mol Cancer. 2010 Aug 5;9:209. doi: 10.1186/1476-4598-9-209.

44.

Synthesis and biological evaluation of arylidene analogues of Meldrum's acid as a new class of antimalarial and antioxidant agents.

Sandhu HS, Sapra S, Gupta M, Nepali K, Gautam R, Yadav S, Kumar R, Jachak SM, Chugh M, Gupta MK, Suri OP, Dhar KL.

Bioorg Med Chem. 2010 Aug 1;18(15):5626-33. doi: 10.1016/j.bmc.2010.06.033. Epub 2010 Jun 17.

PMID:
20621497
45.

2-methoxyestradiol inhibits Barrett's esophageal adenocarcinoma growth and differentiation through differential regulation of the beta-catenin-E-cadherin axis.

Kambhampati S, Banerjee S, Dhar K, Mehta S, Haque I, Dhar G, Majumder M, Ray G, Vanveldhuizen PJ, Banerjee SK.

Mol Cancer Ther. 2010 Mar;9(3):523-34. doi: 10.1158/1535-7163.MCT-09-0845. Epub 2010 Mar 2.

46.

A new iridoid glycoside from Vitex negundo Linn (Verbenacea).

Sharma RL, Prabhakar A, Dhar KL, Sachar A.

Nat Prod Res. 2009;23(13):1201-9. doi: 10.1080/14786410802696494.

PMID:
19731139
47.

Human replication protein A-Rad52-single-stranded DNA complex: stoichiometry and evidence for strand transfer regulation by phosphorylation.

Deng X, Prakash A, Dhar K, Baia GS, Kolar C, Oakley GG, Borgstahl GE.

Biochemistry. 2009 Jul 21;48(28):6633-43. doi: 10.1021/bi900564k.

48.

Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model.

Dhar A, Mehta S, Dhar G, Dhar K, Banerjee S, Van Veldhuizen P, Campbell DR, Banerjee SK.

Mol Cancer Ther. 2009 Feb;8(2):315-23. doi: 10.1158/1535-7163.MCT-08-0762. Epub 2009 Feb 10. Erratum in: Mol Cancer Ther. 2009 Mar;8(3):711.

49.

The diagnostic accuracy of colposcopy in previously treated cervical intraepithelial neoplasia.

Moss EL, Dhar KK, Byrom J, Jones PW, Redman CW.

J Low Genit Tract Dis. 2009 Jan;13(1):5-9. doi: 10.1097/LGT.0b013e31817f36d4.

PMID:
19098599
50.

Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2.

Dhar G, Banerjee S, Dhar K, Tawfik O, Mayo MS, Vanveldhuizen PJ, Banerjee SK.

Cancer Res. 2008 Jun 15;68(12):4580-7. doi: 10.1158/0008-5472.CAN-08-0316.

Supplemental Content

Support Center